The Journey From Diagnosis to Recovery: Lisa Fasone’s Story

Lisa Fasone and her partner aspired to have two children. When Lisa became pregnant in 2021, their dreams seemed within reach. They welcomed their daughter in February 2022. However, adjusting to their new life, Lisa experienced persistent postpartum symptoms, including night sweats and headaches. Initially, she attributed these symptoms to breastfeeding and hormonal changes. Despite stopping nursing, she still felt unwell and was unable to conceive again. By the time her daughter turned two, Lisa felt something was amiss.

Lisa consulted her OB-GYN, who discovered elevated levels of prolactin, a hormone produced by the pituitary gland. Prolactin influences fertility and aids in breast milk production, but Lisa’s levels hadn’t normalized post-pregnancy. Further tests revealed a benign tumor, called a prolactinoma, on her pituitary gland. It was causing excess hormone production leading to her symptoms.

Dr. Stephen McGill, a neurosurgeon at Northwestern University, explained that surgery for such tumors is rare. Instead, it’s commonly treated with oral medication, which may dissolve the tumor over time. Lisa began the medication but faced severe side effects, including dizziness. More troubling was the medication’s incompatibility with pregnancy, compounding her struggle to expand her family.

After a year of treatment, a follow-up scan revealed the tumor was growing instead of shrinking. Despite potential complications, the surgery became a viable option. For Lisa, surgery offered hope for normalcy and the possibility of completing her family.

Lisa underwent the minimally invasive procedure in April 2025. The day after the surgery, her prolactin levels were normal. Thirty days later, she had her first period in nearly four years, a sign that life was returning to normal.

However, subsequent tests showed her prolactin levels rising again, leading to initial despair. Yet, further tests revealed a joyful cause: Lisa was pregnant with her second child.

Lisa gave birth to another daughter in February 2026. Her pregnancy proceeded smoothly, and her prolactin levels returned to normal, allowing her to breastfeed her new child. Her first daughter embraced her role as a big sister.

Lisa returned to work and completed her doctorate in medical science amidst the whirlwind of changes. She expressed gratitude for her family’s current state.

Dr. McGill and Lisa’s endocrinologist will monitor her prolactin levels regularly to ensure her continued health. Annual MRIs will be conducted for five years, gradually spaced out over time.

Lisa anticipates fewer doctor’s visits as she cherishes the family she longed for. Reflecting on her surgery and subsequent events, she marvels at her journey and recovery.